Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study
Renling Yao; Sufang Lu; Ruifei Xue; Jian Wang; Yuanwang Qiu; Yuxin Chen; Jiacheng Liu; Li Zhu; Jie Zhan; Suling Jiang; Shengxia Yin; Xin Tong; Weimao Ding; Jie Li; Chuanwu Zhu; Rui Huang; Chao Wu;
Ann Hepatol. 2024;29:
Liver steatosis and fibrosis markers¿ association with cardiovascular and renal damage in Japanese adults: the TMM BirThree cohort study
Toshiya Machida; Taku Obara; Mami Ishikuro; Keiko Murakami; Fumihiko Ueno; Aoi Noda; Tomomi Onuma; Fumiko Matsuzaki; Jun Inoue; Shinichi Kuriyama; Nariyasu Mano;
Ann Hepatol. 2023;28: